Tuesday 21st January, 18:00 - 19:00
To start our 2025 webinar series we have Vasileos Kouritas, Consultant in Thoracic Surgery, to share his knowledge and expertise of the role of the multi disciplinary approach for high risk lung cancer patients.
Learning outcomes for this webinar:
- Understand the term “high risk” in Lung cancer surgery patients
- Describe the pathways and practices involved in the treatment of the “high risk” patients in Lung cancer surgery in the UK
- Familiarize with the necessity of establishing a multidisciplinary approach to the surgical treatment of “high risk” lung cancer patients
- Determine the different specialties participation in the formation of the “high risk” meeting
- Describe the outcomes of “high risk” lung cancer patients discussed at an established “high risk” meeting
- Explore future directions and opportunities from endorsing a “high risk” meeting in the surgical practice of lung cancer patients
Chaired by Charlotte Smith, all healthcare professionals are welcome to join this webinar and to participate in the Q&A session that will follow the presentation.
We are grateful to AstraZeneca UK Limited for sponsoring this webinar. It has been developed by LCNUK, and AstraZeneca has had no input into the development, content or production of this material.
If you wish to learn more about AstraZeneca’s lung cancer brands please reach out to your local AstraZeneca Oncology Account Manager.